21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Breakthrough COVID19 Infections after Vaccinations in Healthcare and Other Workers in a Chronic Care Medical Facility in New Delhi, India

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Aims

          Vaccinations are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough infections after vaccinations in a chronic care, diabetes-centric healthcare facility.

          Methods

          We received rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, other staff) in our health care facility from January 16, 2021 till date.

          Results

          Out of 123 employees, 110 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Breakthrough infections occurred in 18 persons (15.9%), 17 of them had incurred it after the second dose. Except one (required hospitalization), all (94.5%) had mild COVID19 disease.

          Conclusions

          High prevalence of mild breakthrough infection is seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges

          Background and aims To summarize the available evidence on the use COVID-19 vaccines in patients with diabetes mellitus. Methods We performed a thorough literature search with regard to COVID-19 vaccines in patients with type 1 and type 2 diabetes mellitus. Results The novel coronavirus disease (COVID-19) tends to portend a poor prognosis in patients with diabetes mellitus (DM). Primary prevention remains the mainstay for mitigating the risks associated with COVID-19 in patients with DM. A significant step in primary prevention is timely vaccination. Routine vaccination against pneumococcal pneumonia, influenza, and hepatitis B is recommended in patients with DM with good efficacy and reasonable safety profile. With clinical data supporting a robust neutralizing antibody response in COVID-19 patients with DM, vaccination in individuals with DM is justified. In fact, as the burden of the disease is borne by people with DM, COVID-19 vaccination should be prioritized in individuals with DM. Multiple unresolved issues with regard to preferred vaccine type, vaccine efficacy and durability, frequency of administration, vaccination in children (<18 years) and pregnant/lactating women remain, and need to be addressed through future research. Conclusions Patients with type 1 and type 2 diabetes mellitus are at a high risk of poor prognosis with COVID-19 and vaccination should be prioritized in them. However, many unresolved issues with regard to COVID-19 vaccination need to be addressed through future research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Vaccine breakthrough infections with SARS-CoV2 variants

                Bookmark

                Author and article information

                Journal
                Diabetes Metab Syndr
                Diabetes Metab Syndr
                Diabetes & Metabolic Syndrome
                Diabetes India. Published by Elsevier Ltd.
                1871-4021
                1878-0334
                3 May 2021
                3 May 2021
                Affiliations
                [a ]Centre of Nutrition & Metabolic Research (C-NET), National Diabetes, Obesity and Cholesterol Foundation (N-DOC), SDA, New Delhi, India
                [b ]Diabetes Foundation (India), SDA, New Delhi
                [c ]Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, Nehru Place, New Delhi
                Author notes
                []Corresponding author. Fortis C-DOC (Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology) B-16, Chirag Enclave, New Delhi-110048, India.
                Article
                S1871-4021(21)00139-9
                10.1016/j.dsx.2021.05.001
                8091733
                33991805
                667dc8d3-4c1b-4628-8552-ae5dc606343d
                © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Comments

                Comment on this article

                scite_
                152
                11
                87
                2
                Smart Citations
                152
                11
                87
                2
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content280

                Cited by62

                Most referenced authors33